NEW YORK, November 5 (RAPSI) - The former wife of Kazakh fertilizer tycoon Bolat Nazarbayev filed courts with a New York City court seeking the dismissal of her ex’s lawsuit against her based on the claim that he has been faking illness in order to avoid depositions, The New York Post reported Monday.

In the initial complaint, Nazarbayev sought to recover a $20 million New York City apartment which was allegedly stolen from him by Nazarbayeva’s son Daniyar, with his mother’s assistance. The complaint describes Nazarbayeva as “an international fugitive currently wanted by INTERPOL.”

The Post reported that she was further accused of having wired $75 million to a jeweler. 

Nazarbayeva reportedly voiced her belief in an affidavit that her former husband’s medical condition had been a fabrication aimed at allowing him to circumvent the court’s rules. She reportedly added that the suit had been brought with the purpose of harassing and embarrassing her.

Nazarbayev’s attorney filed papers with the court earlier this month stating that his client had suffered a “hypertensive emergency,” and was thus unable to travel to New York for a scheduled deposition despite plans to do so. The attorney explained that Nazarbayev had said that he had been instructed by his doctors to remain in their care, but that his client had added: “Once my doctors permit me to leave the clinic and travel I will definitely travel to New York.

In a separate filing, another lawyer for Nazarbayev notes that Nazarbayeva had contended, “Bolat is a healthy individual, who has not suffered from or ever complained about having hypertension or heart disease,” adding that her ex-husband’s had submitted evidence that had been, “fabricated in an effort to circumvent the rules of this Honorable Court.”

Nazarbayev’s attorney refuted these claims, stating that the legal team had previously submitted evidence that their client was suffering from a host of maladies, including: “third-stage arterial hypertension, hypoxic ischemic encephalopathy, ischaemic heart disease, multifocal atherosclerosis, dyslipidemia, type 2 diabetes, visceralabdominal obesity, and steatosis of the liver.”